Literature DB >> 29729780

Mechanisms of, and Adjuvants for, Bone Pain.

Nicholas Figura1, Joshua Smith2, Hsiang-Hsuan Michael Yu3.   

Abstract

Metastatic bone pain is a complex, poorly understood process. Understanding the unique mechanisms causing cancer-induced bone pain may lead to potential therapeutic targets. This article discusses the effects of osteoclast overstimulation within the tumor microenvironment; the role of inflammatory factors at the tumor-nociceptor interface; the development of structural instability, causing mechanical nerve damage; and, ultimately, the neuroplastic changes in the setting of sustained pain. Several adjuvant therapies are available to attenuate metastatic bone pain. This article discusses the role of pharmacologic therapies, surgery, kyphoplasty, vertebroplasty, and radiofrequency ablation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bisphosphonate; Bone; Kyphoplasty; Metastatic; NGF; Pain; RANKL inhibitor; Vertebroplasty

Mesh:

Year:  2018        PMID: 29729780     DOI: 10.1016/j.hoc.2018.01.006

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  8 in total

Review 1.  Integrated CT-Fluoroscopy Equipment: Improving the Interventional Radiology Approach and Patient Experience for Treatment of Musculoskeletal Malignancies.

Authors:  Steven Yevich; Bruno C Odisio; Rahul Sheth; Lambros Tselikas; Thierry de Baère; Frederic Deschamps
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

Review 2.  Percutaneous Cement Injection for the Palliative Treatment of Osseous Metastases: A Technical Review.

Authors:  Steven Yevich; Lambros Tselikas; Guillaume Gravel; Thierry de Baère; Frederic Deschamps
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

3.  Sickle cell bone disease and response to intravenous bisphosphonates in children.

Authors:  C Grimbly; P Diaz Escagedo; J L Jaremko; A Bruce; N Alos; M E Robinson; V N Konji; M Page; M Scharke; E Simpson; Y D Pastore; R Girgis; R T Alexander; L M Ward
Journal:  Osteoporos Int       Date:  2022-07-29       Impact factor: 5.071

Review 4.  Mechanisms of bone pain: Progress in research from bench to bedside.

Authors:  Gehua Zhen; Yuhan Fu; Chi Zhang; Neil C Ford; Xiaojun Wu; Qichao Wu; Dong Yan; Xueming Chen; Xu Cao; Yun Guan
Journal:  Bone Res       Date:  2022-06-06       Impact factor: 13.362

5.  Activation of the P2X7 receptor in midbrain periaqueductal gray participates in the analgesic effect of tramadol in bone cancer pain rats.

Authors:  Pengtao Li; Quan Zhang; Zhi Xiao; Shouyang Yu; Yan Yan; Ying Qin
Journal:  Mol Pain       Date:  2018-09-10       Impact factor: 3.395

Review 6.  Bone Pain in Cancer Patients: Mechanisms and Current Treatment.

Authors:  Renata Zajączkowska; Magdalena Kocot-Kępska; Wojciech Leppert; Jerzy Wordliczek
Journal:  Int J Mol Sci       Date:  2019-11-30       Impact factor: 5.923

7.  Neurotropin alleviates rat osteocarcinoma pain via P2X3 receptor activation in the midbrain periaqueductal gray.

Authors:  Xingfeng Liu; Jingxin He; Zhi Xiao
Journal:  Iran J Basic Med Sci       Date:  2021-10       Impact factor: 2.699

8.  Transcriptomic analysis of long noncoding RNAs and mRNAs expression profiles in the spinal cord of bone cancer pain rats.

Authors:  Xinran Hou; Yingqi Weng; Qulian Guo; Zhuofeng Ding; Jian Wang; Jiajia Dai; Anqi Wei; Zongbin Song
Journal:  Mol Brain       Date:  2020-03-24       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.